Has Javier Prado received payments from drug or device companies?

Yes. Drug and device makers reported $1,525 in general payments to Javier Prado across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Javier Prado did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Javier Prado come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Javier Prado

Child & Adolescent Psychiatry · Fort Pierce, FLNPI 1922148253

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 45.5% of the total.

$1,525in general payments, 2019–2025

Across 75 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$693
Johnson & Johnson$185
AbbVie$83
Collegium Pharmaceutical, Inc.$77
Teva Pharmaceuticals USA, Inc.$61
Ironshore Pharmaceuticals Inc.$57
plus $368 from 14 others

What the payments were for

Food & beverage$1,525100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	41	$693
Johnson & Johnson	4	$185
AbbVie	1	$83
Collegium Pharmaceutical, Inc.	4	$77
Teva Pharmaceuticals USA, Inc.	2	$61
Ironshore Pharmaceuticals Inc.	3	$57
Alkermes, Inc.	3	$55
Otsuka America Pharmaceutical, Inc.	2	$50
Lundbeck LLC	2	$45
Corium, LLC	2	$36
Hologic Sales And Service, LLC	2	$32
AstraZeneca	1	$25
Vanda Pharmaceuticals Inc.	1	$25
Merck	1	$17
Tris Pharma Inc	1	$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15
Therapeuticsmd, Inc.	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$13
Vertical Pharmaceuticals, LLC	1	$13
Neurocrine Biosciences, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$119

How this compares

$1,525 in reported general payments places this provider in the 70th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida →

Other child & adolescent psychiatry in Fort Pierce

Alan TessonFort Pierce$6K
Craig KuninsGulfport$265K
Elias SarkisGainesville$169K
Jeffrey AlvaroSt Petersburg$87K
Rosa Negron MunozLakeland$39K
Sean HoranMiami$17K
Rachel AgustinesLargo$16K
Carlos BorgeSarasota$15K
Justin SpoonerPonte Vedra Beach$12K
Bhaskar RajuOrlando$11K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →